C15H20N8O6
408.37 g/mol
APIDanger
Regadenoson hydrate
CAS875148-45-1
Category
API
Compound Class
Heterocycle
Primary Use
Pharmaceutical Raw Material
Regadenoson hydrate is an active pharmaceutical ingredient used as a pharmaceutical raw material. It is a polar, polycyclic compound containing multiple hydroxyl groups, an amide, and an amine, existing as a hydrated salt-like form.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 875148-45-1
Related Compounds
StrongSame Parent
Regadenoson
CAS313348-27-5
pharmaceutical raw material
ReferenceSame Category
Quisinostat
CAS875320-29-9
pharmaceutical raw material
ReferenceSame Category
Quisinostat dihydrochloride
CAS875320-31-3
pharmaceutical raw material
ReferenceSame Category
Anacetrapib
CAS875446-37-0
pharmaceutical raw material
ReferenceSame Category
Growth hormone releasing hexapeptide
CAS87616-84-0
pharmaceutical raw material
Safety Reference
Danger
H300Fatal if swallowed
H302Harmful if swallowed
H310Fatal in contact with skin
H312Harmful in contact with skin
H315Causes skin irritation
H319Causes serious eye irritation
H330Fatal if inhaled
H332Harmful if inhaled
H335May cause respiratory irritation
H370Causes damage to organs
Identifiers
IUPAC Name
1-[6-amino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]purin-2-yl]-N-methylpyrazole-4-carboxamide;hydrate
InChIKey
CDQVVPUXSPZONN-WPPLYIOHSA-N
SMILES
CNC(=O)C1=CN(N=C1)C2=NC(=C3C(=N2)N(C=N3)[C@H]4[C@@H]([C@@H]([C@H](O4)CO)O)O)N.O
Synonyms (10)
- Regadenoson (USAN)
- Lexiscan (TN)
- REGADENOSON MONOHYDRATE
- Regadenoson hydrate
- Regadenoson hydrate (JAN)